A 2 point procedure for the enzymatic determination of glucose concentrations, using hcxokinase and glucosc-6-phosphate dehydrogenase, was evaluated with a GEMSAEC analyzer. The proposed method appears to be very useful in clinical chemistry for several reasons: it has a high reliability and docs not need a deproteinisation step; with the exception of glucose-6-phosphate, no other substance has been found so far that causes significant interference; a single analysis takes 7.5 minutes; drift and interaction effects can be neglected. Capillary blood, serum, cerebrospinal fluid or urine can be analyzed without the determination of a sample blank value. Blood is collected with 40 μ\ glass capillaries, then transferred into a sodium chloride solution containing maleimide to avoid glycolysis. Under these conditions blood samples can be transported by a pneumatic tube system and stored for several days.
The enzymatic determination of the glucose concenSolutions tration with hexokinase and glucose-6-phosphate de-ι. Sodium chloride solution: 9 g Nad (Merck No. 6404), 200 mg hydrogenase (Hexokinase method) is now widely used maleimide (Schuchardt Nr. MA 084) + bidist. H 2 O to 1000 ml. for clinical purposes. Automatic procedures mostly This solution was stable for at least 4 weeks at room temperature, require the separation of serum proteins before the 2. Glucose standard, 10mmol/l: 450.4mg dried glucose (Merck reaction can be started (1, 2) > + bidist -τ , τ , τ »ru-j· j · · i_ H 2 Oto250ml. sample blank value. This disadvantage is overcome with analyzers which are able to take at least 2 readings 3. Glucose xvorking standard: 4.0ml solution (2) + 50.01 ml . / . solution (1) . This solution was stable for at least 1 month at 4°C during the reaction (14) .
and was added directly to the Rotoloader cups . A GEMSAEC analyzer (3-6) was used to evaluate 4 Potassium di chromate (M erck No. 4864), was dissolved in such a two-point method for the determination of the 0 .01 mol/1 H 2 SO 4 (Merck No. 9982) to give an absorbance of glucose concentration based on a commercially available approx. 0.455 at 340 nm (4.5 mg/1). test combination.
5. Reaction mixture: Solutions 1-4 were taken from the BioBlood samples were taken from finger tips with hep-chemica test combination; the volume of solution 2-4 were arinked glass capillaries as recently described (2, 7) and chosen to °P* mize the concentration of enzymes and cofactors r i · j-ι ι · j Λ /ce\r\ i\ (Fig-l ac )· The concentrations of the enzyme suspension were transferred into sodium chloride solution (500^1) no r a ltered because these investigations ought to be based on the containing maleimide to avoid glycolysis (8).
commercially available test combination. The slight downward deflection of the saturation curve in Figure Ic at The optimal concentrations of cofactors and enzymes. The reaction mixture is the same as described under methods, except for ATP in Fig. la , NADP in Fig. 1 b and the enzyme suspension in Fig. 1 Methods · , \ Blood samples (40 μϊ) were taken with heparinized glass capillaries after skin puncture. The filled capillaries were introduced into an Eppendorf reaction cup with 500 μ\ saline solution which contained maleimide to delay glycolysis (Tab. 1). After the cup was closed and shaken it could be either stored at 4°C or transported by a pneumatic tube system. The reaction cups were filled up to 4 weeks prior to use. During this time the fluid loss did not exceed 1% if the cups were carefully closed and stored at room temperature.
Tab. 1
The stability of the glucose concentration (mmol/1) in 40 μ\ blood samples taken up in 500 μ\ sodium chloride (9 g/1). Blood was aspirated in monovettes containing heparinized beads, distributed into various reaction cups filled with NaCl solution and stored as indicated below.
Each value is a mean of 2 determinations. Prior to the analysis, the reaction cup was centrifuged for l min in an Eppendorf microcentrifuge without removing the glass capillary. The supernatant could either be transferred to a Rotoloader or directly to a cuvette-rotor using a 50 μΐ Eppendorf pipette. The protocol for the Rotoloader and the GEMSAEC analyzer are summarized in Table 2 . If 20 μ\ glass capillaries are used, the sample volume must be increased to 100 μϊ. The analyzer automatically takes 8 readings (during approx. 1 second) for the first and for the second point. The difference of both mean values is printed out together with the final result (in mmol/1). : control serum or unknown sample. The recovery of glucose added to various serum samples was calculated from the results of the following assays: 1. 9.0ml bidist. H 2 O + 1.0ml glucose solution (100 mmol/1); 2. 9.0ml pooled serum + 1-0 glucose solution (100 mmol/1); 3. 9.0 ml pooled serum + 1.0 mi bidist. H 2 O.
Sequence of samples
The interaction from low to high concentrations (Qj) and from high to low concentrations (Q 2 ) was determined as recently reported (10) and expressed as the percent interaction coefficient: Q = 100 X q. (For the explanation of q see 9, 10, 11). The detection limit was determined by using bidist. H 2 O as a sample during 20 runs with the two-point procedure: the threefold standard deviation of the mean value is a measure for the detection limit according to KAISER (12) .
Statistical analysis
For the determination of the precision 2 identical serum samples (x a , Xb) are serially analyzed. The precision-within-series 100 · x) (CV S = is calculated from the x a and xt> values: Xbl) ,.
2m
The precision-from-day-to-day is calculated from the x*r (or the Xb-) values:
(2)Xa = n-l Z. Klin. Chenu Klin. Biochem! / 11. Jahrg. 1973 / Heft 6
Results
Preparation of samples During these investigations disposable 40 μΐ gkss capillaries were used for blood sampling. Their precision was tested by weighing bidist. H 2 0:39.76 ± 0.26 μ\ (η = 32). The coefficient of variation was 0.6% (room temperature was taken into account).
Recently it was reported that even 20 μ\ capillaries can be used with sufficient precision for clinical purposes (2, 7).
Precision
The overall precision of the optical and the read-out system was determined by dichromate solutions of varying concentrations (Fig. 2) . The data obtained agreed well with those reported by MACLIN (13). The precision of the Rotoloader and the overall [precision of the glucose determination are summarized in Table 3 and 4. The precision from-day-to-day (Tab. 4b) was In most cases, analyzer runs are started only once a day after a series has been completed. These series usually consist of several segments (11). When a sequence of for instance 100 samples has to be analyzed with a GEMSAEC, it is a matter of definition to consider each run a series per se or just a segment of the whole series. For the purpose of comparing precision data from various analytic systems, it is suggested that each run be regarded as a series per se. Three types of precision can then be expected: 1. the precision withinseries, 2. the precision between-series (during 1 day) and 3. the precision from-day-to-day. The precision between-series (interbatch precision) must be differentiated from the precision from-day-today as shown in Table 5 : 10 suceeding runs of the same control serum were analyzed for 8 days. The coefficient of variation (CV) was calculated for each run: XGV = 2.1%. The precision between-series can be estimated from the first (or any other) value of each run during a day. The mean value of 8 days was 3.4%. In the same way, the precision from-day-to-day can be calculated from the first (or any other) value of the first (or any other) run during the 8 days (Tab. 5).
Tab. 5 The 3 types of precision observed with a GEMSAEC analyzer using Behring control serum (Lot. No. 112). Each run yielded 12 values which were referred to 1 standard value (10 mmol/1), and was daily repeated ten times for 8 days. The mean value of all determinations was 5.2 mmol/1 (n =960)
Type of precision Coefficient of variation*)
1. Precision within-series II. Precision between-series II. Precision from-day-to-day 2.1 (n= 80) 3.4 (n = 96) 4.9 (n = 120) *) Coefficient of variation *) mean value of η calculations The detection limit determined according to KAISER (12) was 0.13 mmol/1; the range of extreme values was 0.000-0.002 absorbance units.
Accuracy
The 2-point procedure of the hexokinase method appeared to be linear between 0 and 20 mmol/1 (Fig. 3) . This range covers 99% of the routine and about 95% of all emergency glucose determinations performed in our hospital. Glucose was added to various serum samples. The recovery varied from 100.0% to 100.7% (Tab. 6). Furthermore, we measured the glucose concentration in capillary blood with the 2-point-and with an endpoint method. The latter included a deproteinisation step and was recently investigated in detail by us (2) . The correlation between both procedures was sufficient for clinical purposes (Fig. 4) .
Interferences
Recently, we have reported (2) that the glucose values are slightly higher as expected in the presence of fructose using the hexokinase method and the endpoint deter- 
Interaction
Recently we have differentiated between cyclic-and from-sample-to-sample interaction effects (11).
Interaction from-sample-to-sample was not detected Tab. 6 Recovery of glucose added to various human serum samples and to aqueous solutions containing possible interfering substances. The "interaction-safe range" (10, 11) of the glucose determination with the GEMSAEC system. The concentrations forming this range are calculated according to (10): ci,i for the interaction from low to high concentrations and C2,i for the interaction from high to low concentrations. The standard deviations are taken from Table 4 . Q = 0.3% (n = 5). It is postulated that the error due to carry-over effects should be lower than the twofold (hatched area) or the threefold value of the intrabatch precision (standard deviation) in the linear range of the 2-point procedure, from low to high, or from high to low concentrations. However, if a sample with 100 mmol/l is followed by 3 samples with 2 mmol/l glucose, a mean Q 2 value of 0.3% (s = 0.1, n = 5) was determined. This slight interaction effect will cause serious errors only under extreme conditions: as a rule of thumb, we suggest that all samples be reanalyzed with a glucose concentration below 2 mmol/l if the preceeding concentration exceeds 50 mmol/l (Fig. 5 ). This type of interaction occurs only at the Rotoloader station. If the rotor is loaded manually, carry over effects are not to be expected. Cyclic interaction effects are encountered if the washing step is unsufficient. 2 successive runs were performed with the same rotor using various albumin solutions (Tab. 7). No significant cyclic interaction was detected with the biuret reaction. Urine samples Urine and cerebrospinal fluid samples were diluted with NaCl (9 g/1) containing maleimide and analyzed for their glucose concentration in the same way as capillary blood. The comparison with an endpoint procedure of the hexokinase method (2) , which includes the precipitation of proteins and the determination of a blank value for urine samples, shows an acceptable correlation (Fig. 6 ).
Discussion
The GEMSAEC analyzer permits a 2-point procedure of the hexokinase method which is precise enough for the determination of glucose concentrations for clinical purposes. This method has 3 distinct advantages over a mechanized endpoint procedure recently described by us (2): 1. it is subject to less interference (Tab. 6), despite the fact that deproteinisation is not carried out, 2. single samples are processed more rapidly (Tab. 8), and 3. urine can be analyzed without performing a sample blank value. A further advantage of the GEMSAEC system is that carry-over effects can almost be neglected. Whereas the analyzer itself does not contribute to the over-all interaction from sample to sample, the Rotoloader causes such an effect. However, the prerinsing device and the cleaning of the sample-pick-up tip with a small sponge keeps the sample carry-over extremely low. Determinations, which require a high precision and meet a relatively large range of extreme values, e. g. the glucose concentration in human material, should be performed with low interaction effects (10, 11). The over-all kinetics of the hexokinase and glucose-6-phosphate dehydrogenase reaction follow an exponential curve and will be discussed in a following report.
